首页> 美国卫生研究院文献>Journal of Cellular and Molecular Medicine >Epigenetic silencing of the WNT antagonist Dickkopf 3 disrupts normal Wnt/β-catenin signalling and apoptosis regulation in breast cancer cells
【2h】

Epigenetic silencing of the WNT antagonist Dickkopf 3 disrupts normal Wnt/β-catenin signalling and apoptosis regulation in breast cancer cells

机译:WNT拮抗剂Dickkopf 3的表观遗传沉默破坏了正常Wnt /β-catenin信号传导和乳腺癌细胞的凋亡调控

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Dickkopf-related protein 3 (DKK3) is an antagonist of Wnt ligand activity. Reduced DKK3 expression has been reported in various types of cancers, but its functions and related molecular mechanisms in breast tumorigenesis remain unclear. We examined the expression and promoter methylation of DKK3 in 10 breast cancer cell lines, 96 primary breast tumours, 43 paired surgical margin tissues and 16 normal breast tissues. DKK3 was frequently silenced in breast cell lines (5/10) by promoter methylation, compared with human normal mammary epithelial cells and tissues. DKK3 methylation was detected in 78% of breast tumour samples, whereas only rarely methylated in normal breast and surgical margin tissues, suggesting tumour-specific methylation of DKK3 in breast cancer. Ectopic expression of DKK3 suppressed cell colony formation through inducing G0/G1 cell cycle arrest and apoptosis of breast tumour cells. DKK3 also induced changes of cell morphology, and inhibited breast tumour cell migration through reversing epithelial-mesenchymal transition (EMT) and down-regulating stem cell markers. DKK3 inhibited canonical Wnt/β-catenin signalling through mediating β-catenin translocation from nucleus to cytoplasm and membrane, along with reduced active-β-catenin, further activating non-canonical JNK signalling. Thus, our findings demonstrate that DKK3 could function as a tumour suppressor through inducing apoptosis and regulating Wnt signalling during breast tumorigenesis.
机译:Dickkopf相关蛋白3(DKK3)是Wnt配体活性的拮抗剂。已经报道了在各种类型的癌症中DKK3表达降低,但是其在乳腺肿瘤发生中的功能和相关的分子机制仍然不清楚。我们检查了DKK3在10个乳腺癌细胞系,96个原发性乳腺肿瘤,43个配对的手术边缘组织和16个正常乳腺组织中的表达和启动子甲基化。与人正常的乳腺上皮细胞和组织相比,DKK3在乳腺癌细胞系中经常被启动子甲基化沉默(5/10)。在78%的乳腺肿瘤样本中检测到DKK3甲基化,而在正常乳腺和手术边缘组织中只有极少数甲基化,表明DKK3在乳腺癌中具有肿瘤特异性甲基化。 DKK3的异位表达通过诱导G0 / G1细胞周期停滞和乳腺癌细胞凋亡来抑制细胞集落形成。 DKK3还通过逆转上皮-间质转化(EMT)和下调干细胞标记物来诱导细胞形态变化,并抑制乳腺肿瘤细胞迁移。 DKK3通过介导β-catenin从细胞核到细胞质和膜的转运来抑制经典Wnt /β-catenin信号传导,同时减少活性β-catenin,进一步激活非经典JNK信号传导。因此,我们的发现证明DKK3可以通过在乳腺肿瘤发生过程中诱导细胞凋亡和调节Wnt信号传导来充当肿瘤抑制因子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号